In defense of phage: Viral suppressors of CRISPR-mediated adaptive immunity in bacteria

RNA Biology

Volumn 10, Issue 5, 2013, Pages 886-890

  Wiedenheft, Blake ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

Anti CRISPR; Bacterial immunity; Phage; RNA guided immunity; Viral suppressors of CRISPR (VSC); Viral suppressors of RNAi (VSR)

Indexed keywords

BIOLOGICAL PRODUCT; NUCLEIC ACID; ARCHAEAL RNA; BACTERIAL RNA; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ANTIBIOTIC RESISTANCE; ARCHAEON; BACTERIAL GENE; BACTERIOPHAGE; BACTERIUM; CLUSTERS OF REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; DEFENSE MECHANISM; DNA DEGRADATION; GENE LOCUS; GENETIC TRANSCRIPTION; IMMUNE SYSTEM; NONHUMAN; NOTE; PLASMID; RNA INTERFERENCE; VIRUS; VIRUS INFECTION; ARCHAEAL VIRUS; BACTERIA; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY;

BACTERIA (MICROORGANISMS);

ADAPTIVE IMMUNITY; ARCHAEA; ARCHAEAL VIRUSES; BACTERIA; BACTERIOPHAGES; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; DRUG RESISTANCE, BACTERIAL; PLASMIDS; RNA, ARCHAEAL; RNA, BACTERIAL; VIRAL PROTEINS;

EID: 84879032013     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.23591     Document Type: Note

References (41)

1. Labrie SJ, Samson JE, Moineau S. Bacteriophage resistance mechanisms. Nat Rev Microbiol 2010; 8:317-27; PMID:20348932; http://dx.doi.org/10.1038/ nrmicro2315.
2. Bhaya D, Davison M, Barrangou R. CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. Annu Rev Genet 2011; 45:273-97; PMID:22060043; http://dx.doi.org/10.1146/annurev-genet- 110410-132430.
3. Marraffini LA, Sontheimer EJ. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet 2010; 11:181-90; PMID:20125085; http://dx.doi.org/10.1038/nrg2749.
4. Westra ER, Swarts DC, Staals RH, Jore MM, Brouns SJ, van der Oost J. The CRISPRs, they are a-changin': how prokaryotes generate adaptive immunity. Annu Rev Genet 2012; 46:311-39; PMID:23145983; http://dx.doi.org/10.1146/annurev- genet-110711-155447.
5. Wiedenheft B, Sternberg SH, Doudna JA. RNA-guided genetic silencing systems in bacteria and archaea. Nature 2012; 482:331-8; PMID:22337052; http://dx.doi.org/10.1038/nature10886.
6. van der Oost J, Brouns SJ. RNAi: prokaryotes get in on the act. Cell 2009; 139:863-5; PMID:19945373; http://dx.doi.org/10.1016/j.cell.2009.11.018.
7. Meyerson NR, Sawyer SL. Two-stepping through time: mammals and viruses. Trends Microbiol 2011; 19:286-94; PMID:21531564; http://dx.doi.org/10.1016/j. tim.2011.03.006.
8. Van Valen L. A new evolutionary law. Evol Theory 1973; 1:1-30.
9. Matranga C, Zamore PD. Small silencing RNAs. Curr Biol 2007; 17:R789-93; PMID:17878043; http://dx.doi.org/10.1016/j.cub.2007.07.014.
10. Obbard DJ, Gordon KHJ, Buck AH, Jiggins FM. The evolution of RNAi as a defence against viruses and transposable elements. Philos Trans R Soc Lond B Biol Sci 2009; 364:99-115; PMID:18926973; http://dx.doi.org/10.1098/rstb.2008. 0168.
11. Waterhouse PM, Wang MB, Lough T. Gene silencing as an adaptive defence against viruses. Nature 2001; 411:834-42; PMID:11459066; http://dx.doi.org/10. 1038/35081168.
12. van Rij RP, Andino R. The silent treatment: RNAi as a defense against virus infection in mammals. Trends Biotechnol 2006; 24:186-93; PMID:16503061; http://dx.doi.org/10.1016/j.tibtech.2006.02.006.
13. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409:363-6; PMID:11201747; http://dx.doi.org/10.1038/35053110.
14. Macrae IJ, Zhou K, Li F, Repic A, Brooks AN, Cande WZ, et al. Structural basis for double-stranded RNA processing by Dicer. Science 2006; 311:195-8; PMID:16410517; http://dx.doi.org/10.1126/science.1121638.
15. Jinek M, Doudna JA. A three-dimensional view of the molecular machinery of RNA interference. Nature 2009; 457:405-12; PMID:19158786; http://dx.doi.org/10.1038/nature07755.
16. Burgyán J, Havelda Z. Viral suppressors of RNA silencing. Trends Plant Sci 2011; 16:265-72; PMID:21439890; http://dx.doi.org/10.1016/j.tplants. 2011.02.010.
17. Ding SW, Voinnet O. Antiviral immunity directed by small RNAs. Cell 2007; 130:413-26; PMID:17693253; http://dx.doi.org/10.1016/j.cell.2007.07.039.
18. Wu Q, Wang X, Ding SW. Viral suppressors of RNA-based viral immunity: host targets. Cell Host Microbe 2010; 8:12-5; PMID:20638637; http://dx.doi.org/10.1016/j.chom.2010.06.009.
19. Hale CR, Zhao P, Olson S, Duff MO, Graveley BR, Wells L, et al. RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 2009; 139:945-56; PMID:19945378; http://dx.doi.org/10.1016/j.cell.2009.07.040.
20. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012; 337:816-21; PMID:22745249; http://dx.doi.org/10.1126/science. 1225829.
21. Lintner NG, Kerou M, Brumfield SK, Graham S, Liu H, Naismith JH, et al. Structural and functional characterization of an archaeal clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for antiviral defense (CASCADE). J Biol Chem 2011; 286:21643-56; PMID:21507944; http://dx.doi.org/10.1074/jbc.M111.238485.
22. Wiedenheft B, Lander GC, Zhou K, Jore MM, Brouns SJ, van der Oost J, et al. Structures of the RNA-guided surveillance complex from a bacterial immune system. Nature 2011; 477:486-9; PMID:21938068; http://dx.doi.org/10.1038/ nature10402.
23. Wiedenheft B, van Duijn E, Bultema JB, Waghmare SP, Zhou K, Barendregt A, et al. RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc Natl Acad Sci USA 2011; 108:10092-7; PMID:21536913; http://dx.doi.org/10.1073/pnas.1102716108.
24. Zhang J, Rouillon C, Kerou M, Reeks J, Brugger K, Graham S, et al. Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity. Mol Cell 2012; 45:303-13; PMID:22227115; http://dx.doi.org/10.1016/j. molcel.2011.12.013.
25. Cady KC, Bondy-Denomy J, Heussler GE, Davidson AR, O'Toole GA. The CRISPR/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages. J Bacteriol 2012; 194:5728-38; PMID:22885297; http://dx.doi.org/10.1128/JB.01184-12.
26. Deveau H, Barrangou R, Garneau JE, Labonté J, Fremaux C, Boyaval P, et al. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol 2008; 190:1390-400; PMID:18065545; http://dx.doi.org/10.1128/JB.01412-07.
27. Garneau JE, Dupuis MÈ, Villion M, Romero DA, Barrangou R, Boyaval P, et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 2010; 468:67-71; PMID:21048762; http://dx.doi.org/10.1038/ nature09523.
28. Semenova E, Jore MM, Datsenko KA, Semenova A, Westra ER, Wanner B, et al. Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc Natl Acad Sci USA 2011; 108:10098-103; PMID:21646539; http://dx.doi.org/10.1073/pnas.1104144108.
29. Andersson AF, Banfield JF. Virus population dynamics and acquired virus resistance in natural microbial communities. Science 2008; 320:1047-50; PMID:18497291; http://dx.doi.org/10.1126/science.1157358.
30. Levin BR. Nasty viruses, costly plasmids, population dynamics, and the conditions for establishing and maintaining CRISPR-mediated adaptive immunity in bacteria. PLoS Genet 2010; 6:e1001171; PMID:21060859; http://dx.doi.org/10. 1371/journal.pgen.1001171.
31. Weinberger AD, Sun CL, Pluciski MM, Denef VJ, Thomas BC, Horvath P, et al. Persisting viral sequences shape microbial CRISPR-based immunity. PLoS Comput Biol 2012; 8:e1002475; PMID:22532794; http://dx.doi.org/10.1371/journal. pcbi.1002475.
32. Rodriguez-Valera F, Martin-Cuadrado AB, Rodriguez-Brito B, Pasiæ L, Thingstad TF, Rohwer F, et al. Explaining microbial population genomics through phage predation. Nat Rev Microbiol 2009; 7:828-36; PMID:19834481; http://dx.doi.org/10.1038/nrmicro2235.
33. Bondy-Denomy J, Pawluk A, Maxwell KL, Davidson AR. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 2012; In press; PMID:23242138; http://dx.doi.org/10.1038/nature11723.
34. van der Oost J, Jore MM, Westra ER, Lundgren M, Brouns SJ. CRISPR-based adaptive and heritable immunity in prokaryotes. Trends Biochem Sci 2009; 34:401-7; PMID:19646880; http://dx.doi.org/10.1016/j.tibs.2009.05.002.
35. Haft DH, Selengut J, Mongodin EF, Nelson KE. A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes. PLoS Comput Biol 2005; 1:e60; PMID:16292354; http://dx.doi.org/10.1371/journal.pcbi.0010060.
36. Makarova KS, Grishin NV, Shabalina SA, Wolf YI, Koonin EV. A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct 2006; 1:7; PMID:16545108; http://dx.doi.org/10.1186/1745-6150-1-7.
37. Makarova KS, Haft DH, Barrangou R, Brouns SJ, Charpentier E, Horvath P, et al. Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 2011; 9:467-77; PMID:21552286; http://dx.doi.org/10.1038/nrmicro2577.
38. Hankin EH. L'action bactericide des eaux de la Jumna et du Gange sur le vibrion du cholera. Ann Inst Pasteur (Paris) 1896; 10:511-23.
39. Keen EC. Phage therapy: concept to cure. Front Microbiol 2012; 3:238; PMID:22833738; http://dx.doi.org/10.3389/fmicb.2012.00238.
40. Lakatos L, Csorba T, Pantaleo V, Chapman EJ, Carrington JC, Liu YP, et al. Small RNA binding is a common strategy to suppress RNA silencing by several viral suppressors. EMBO J 2006; 25:2768-80; PMID:16724105; http://dx.doi.org/10. 1038/sj.emboj.7601164.
41. Jin H, Zhu JK. A viral suppressor protein inhibits host RNA silencing by hooking up with Argonautes. Genes Dev 2010; 24:853-6; PMID:20439425; http://dx.doi.org/10.1101/gad.1927310.